CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Executive VP, COO, PEO, CFO acquired 45,000 shares (grant or award)
- 4 Open-market sale VP and General Counsel sold 3,766 shares at $6.68 ($25,157)
- 4 Open-market sale VP, Clinical Development sold 2,700 shares at $7.06 ($19,062)
- 4 Shares withheld for taxes VP, Research gave up 591 shares (to pay taxes)
- 4 Shares withheld for taxes COO and Princ. Exec. Officer gave up 886 shares (to pay taxes)
- 4 Shares withheld for taxes VP and General Counsel gave up 2,067 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Clinical Development gave up 2,952 shares (to pay taxes)
- 4 Grant or award VP, Clinical Development acquired 8,000 shares (grant or award)
- 4 Grant or award VP and General Counsel acquired 10,000 shares (grant or award)
- 4 Grant or award COO and Princ. Exec. Officer acquired 35,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 14,764 shares (grant or award)
- 4 Grant or award Director acquired 7,382 shares (grant or award)
- 4 Grant or award Director acquired 12,919 shares (grant or award)
- 4 Grant or award Director acquired 7,382 shares (grant or award)
Page 5 of 28 · 560 filings